Search research articles
Contact Us
Filters
Showing results (11-20 of 114) with videos related to
Page
of 12
Sort By:
Expert Opinion on Emerging Drugs
|
June 10, 2008
Cancer vaccines: on the threshold of success
Leisha A Emens
Oncology (Williston Park, N.Y.)
|
May 22, 2013
HER2-directed therapy for metastatic breast cancer
Danijela Jelovac, Leisha A Emens
Cancer Immunology, Immunotherapy : CII
|
February 8, 2013
Chemoimmunotherapy: reengineering tumor immunity
Gang Chen, Leisha A Emens
Discovery Medicine
|
July 31, 2010
GM-CSF-secreting vaccines for solid tumors: moving forward
Richa Gupta, Leisha A Emens
Cancer Immunology Research
|
May 6, 2015
The interplay of immunotherapy and chemotherapy: harnessing potential synergies
Leisha A Emens, Gary Middleton
Cold Spring Harbor Perspectives in Medicine
|
April 3, 2023
Immunotherapy Approaches for Breast Cancer Patients in 2023
Leisha A Emens, Sherene Loi
International Immunopharmacology
|
July 20, 2010
The multikinase inhibitor sorafenib reverses the suppression of IL-12 and enhancement of IL-10 by PGE₂ in murine macrophages
Justin P Edwards, Leisha A Emens
Journal for Immunotherapy of Cancer
|
June 20, 2018
Targeting adenosine for cancer immunotherapy
Robert D Leone, Leisha A Emens
Seminars in Oncology
|
June 22, 2020
The evolving management of metastatic triple negative breast cancer
Monica K Malhotra, Leisha A Emens
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 23, 2003
Adjuvant hormonal therapy for premenopausal women with breast cancer
Leisha A Emens, Nancy E Davidson
Page
of 12
Search research articles
Search
Showing results (11-20 of 114) with videos related to
Sort By:
Page
of 12
Expert Opinion on Emerging Drugs
|
June 10, 2008
Cancer vaccines: on the threshold of success
Leisha A Emens
Oncology (Williston Park, N.Y.)
|
May 22, 2013
HER2-directed therapy for metastatic breast cancer
Danijela Jelovac, Leisha A Emens
Cancer Immunology, Immunotherapy : CII
|
February 8, 2013
Chemoimmunotherapy: reengineering tumor immunity
Gang Chen, Leisha A Emens
Discovery Medicine
|
July 31, 2010
GM-CSF-secreting vaccines for solid tumors: moving forward
Richa Gupta, Leisha A Emens
Cancer Immunology Research
|
May 6, 2015
The interplay of immunotherapy and chemotherapy: harnessing potential synergies
Leisha A Emens, Gary Middleton
Cold Spring Harbor Perspectives in Medicine
|
April 3, 2023
Immunotherapy Approaches for Breast Cancer Patients in 2023
Leisha A Emens, Sherene Loi
International Immunopharmacology
|
July 20, 2010
The multikinase inhibitor sorafenib reverses the suppression of IL-12 and enhancement of IL-10 by PGE₂ in murine macrophages
Justin P Edwards, Leisha A Emens
Journal for Immunotherapy of Cancer
|
June 20, 2018
Targeting adenosine for cancer immunotherapy
Robert D Leone, Leisha A Emens
Seminars in Oncology
|
June 22, 2020
The evolving management of metastatic triple negative breast cancer
Monica K Malhotra, Leisha A Emens
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 23, 2003
Adjuvant hormonal therapy for premenopausal women with breast cancer
Leisha A Emens, Nancy E Davidson
Page
of 12